Skip to main content
SpringerLink
Log in

Anxious depression: Clinical features and treatment

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Anxious depression has been conceptualized in at least two related but separate ways: 1) major depressive disorder with at least one comorbid Axis I anxiety disorder and 2) major depressive disorder with a high level of anxiety with or without one or more comorbid Axis I anxiety disorders. Using either definition, patients with anxious depression seem to have a more chronic course of illness, an increased incidence of suicidal thoughts and behavior, greater functional and occupational impairment, and poorer response to treatment. Multiple classes of medications are used to treat anxious depression, most commonly first- and second-generation antidepressants, atypical antipsychotics, and benzodiazepines. Certain patients with anxious depression may require lower starting doses, more gradual dose escalations, higher end point doses, longer duration of treatment, and/or early augmentation with other agents. Nonpharmacologic treatments such as targeted psychotherapy and preventative stepped-care approaches also may be effective. Well-conceived, randomized controlled treatment trials are necessary to make further gains in the management of patients with anxious depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Fava M, Rush AJ, Alpert JE, et al.: What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry 2006, 51:823–835.

    PubMed  Google Scholar 

  2. Dunlop BW, Davis PG: Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review. Prim Care Companion J Clin Psychiatry 2008, 10:222–228.

    Article  PubMed  Google Scholar 

  3. Kennedy SH: Treating each and every depressed patient. J Psychopharmacol 2008, 22:19–23.

    Article  CAS  PubMed  Google Scholar 

  4. Hettema JM: What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet 2008, 148C:140–146.

    Article  PubMed  Google Scholar 

  5. Kendler KS, Gardner CO, Gatz M, Pedersen NL: The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med 2007, 37:453–462.

    Article  PubMed  Google Scholar 

  6. Melartin TK, Rytsala HJ, Leskela US, et al.: Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry 2002, 63:126–134.

    PubMed  Google Scholar 

  7. Zimmerman M, McDermut W, Mattia JI: Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. Am J Psychiatry 2000, 157:1337–1340.

    Article  CAS  PubMed  Google Scholar 

  8. Fava M, Rankin MA, Wright EC, et al.: Anxiety disorders in major depression. Compr Psychiatry 2000, 41:97–102.

    Article  CAS  PubMed  Google Scholar 

  9. Hasin DS, Goodwin RD, Stinson FS, Grant BF: Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005, 62:1097–1106.

    Article  PubMed  Google Scholar 

  10. Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8–19.

    CAS  PubMed  Google Scholar 

  11. Joffe RT, Bagby RM, Levitt A: Anxious and nonanxious depression. Am J Psychiatry 1993, 150:1257–1258.

    CAS  PubMed  Google Scholar 

  12. Brown GW, Harris TO, Eales MJ: Social factors and comorbidity of depressive and anxiety disorders. Br J Psychiatry Suppl 1996, June:50–57.

  13. Fava M, Uebelacker LA, Alpert JE, et al.: Major depressive subtypes and treatment response. Biol Psychiatry 1997, 42:568–576.

    Article  CAS  PubMed  Google Scholar 

  14. Tollefson GD, Holman SL, Sayler ME, Potvin JH: Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 1994, 55:50–59.

    CAS  PubMed  Google Scholar 

  15. Clayton PJ, Grove WM, Coryell W, et al.: Follow-up and family study of anxious depression. Am J Psychiatry 1991, 148:1512–1517.

    CAS  PubMed  Google Scholar 

  16. Simon NM: Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse. J Clin Psychiatry 2009, 70(Suppl 2):10–14.

    Article  PubMed  Google Scholar 

  17. Moffitt TE, Harrington H, Caspi A, et al.: Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry 2007, 64:651–660.

    Article  PubMed  Google Scholar 

  18. Slade T, Watson D: The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population. Psychol Med 2006, 36:1593–1600.

    Article  PubMed  Google Scholar 

  19. Simon NM, Zalta AK, Otto MW, et al.: The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res 2007, 41:255–264.

    Article  PubMed  Google Scholar 

  20. Fava M, Rush AJ, Alpert JE, et al.: Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008, 165:342–351.

    Article  PubMed  Google Scholar 

  21. Fava M, Alpert JE, Carmin CN, et al.: Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 2004, 34:1299–1308.

    Article  PubMed  Google Scholar 

  22. Russell JM, Koran LM, Rush J, et al.: Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depress Anxiety 2001, 13:18–27.

    Article  CAS  PubMed  Google Scholar 

  23. Van der Weele GM, Gussekloo J, De Waal MW, et al.: Co-occurrence of depression and anxiety in elderly subjects aged 90 years and its relationship with functional status, quality of life and mortality. Int J Geriatr Psychiatry 2009, 24:595–601.

    Article  PubMed  Google Scholar 

  24. Nelson JC, Delucchi K, Schneider LS: Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis. Int J Geriatr Psychiatry 2009, 24:539–544.

    Article  PubMed  Google Scholar 

  25. Domschke K, Deckert J, Arolt V, Baune B: Anxious versus non-anxious depression: difference in treatment outcome. J Psychopharmacol 2008 Oct 6 (Epub ahead of print).

  26. Helzer JE, Kraemer HC, Krueger RF: The feasibility and need for dimensional psychiatric diagnoses. Psychol Med 2006, 36:1671–1680.

    Article  PubMed  Google Scholar 

  27. Regier DA: Dimensional approaches to psychiatric classification: refining the research agenda for DSM-V: an introduction. Int J Methods Psychiatr Res 2007, 16(Suppl 1):S1–S5.

    Article  PubMed  Google Scholar 

  28. Farabaugh A, Mischoulon D, Fava M, et al.: The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients. Int Clin Psychopharmacol 2005, 20:87–91.

    Article  PubMed  Google Scholar 

  29. Schoevers RA, Van HL, Koppelmans V, et al.: Managing the patient with co-morbid depression and an anxiety disorder. Drugs 2008, 68:1621–1634.

    Article  CAS  PubMed  Google Scholar 

  30. Panzer MJ: Are SSRIs really more effective for anxious depression? Ann Clin Psychiatry 2005, 17:23–29.

    Article  PubMed  Google Scholar 

  31. Zisook S: A clinical overview of monoamine oxidase inhibitors. Psychosomatics 1985, 26:240–246, 251.

    CAS  PubMed  Google Scholar 

  32. Amsterdam JD: A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. J Clin Psychiatry 2003, 64:208–214.

    Article  CAS  PubMed  Google Scholar 

  33. Zimmerman M, Posternak M, Friedman M, et al.: Which factors influence psychiatrists’ selection of antidepressants? Am J Psychiatry 2004, 161:1285–1289.

    Article  PubMed  Google Scholar 

  34. Papakostas GI, Stahl SM, Krishen A, et al.: Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. J Clin Psychiatry 2008, 69:1287–1292.

    Article  CAS  PubMed  Google Scholar 

  35. Zisook S, Rush AJ, Haight BR, et al.: Use of bupropion in combination with serotonin reuptake inhibitors. Biol Psychiatry 2006, 59:203–210.

    Article  CAS  PubMed  Google Scholar 

  36. Flint AJ: Generalised anxiety disorder in elderly patients: epidemiology, diagnosis and treatment options. Drugs Aging 2005, 22:101–114.

    Article  PubMed  Google Scholar 

  37. Nelson JC: Anxious depression and response to treatment. Am J Psychiatry 2008, 165:297–299.

    Article  PubMed  Google Scholar 

  38. Brown C, Schulberg HC, Madonia MJ, et al.: Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996, 153:1293–1300.

    CAS  PubMed  Google Scholar 

  39. Unutzer J, Katon W, Callahan CM, et al.: Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002, 288:2836–2845.

    Article  PubMed  Google Scholar 

  40. Woody S, McLean PD, Taylor S, Koch WJ: Treatment of major depression in the context of panic disorder. J Affect Disord 1999, 53:163–174.

    Article  CAS  PubMed  Google Scholar 

  41. McLean PD, Woody S, Taylor S, Koch WJ: Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy. J Consult Clin Psychol 1998, 66:240–247.

    Article  CAS  PubMed  Google Scholar 

  42. Fava GA, Ruini C, Rafanelli C, et al.: Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 2004, 161:1872–1876.

    Article  PubMed  Google Scholar 

  43. Hollon SD, Jarrett RB, Nierenberg AA, et al.: Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry 2005, 66:455–468.

    Article  PubMed  Google Scholar 

  44. van’t Veer-Tazelaar PJ, van Marwijk HW, van Oppen P, et al.: Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. Arch Gen Psychiatry 2009, 66:297–304.

    Article  Google Scholar 

  45. Trivedi MH, Rush AJ, Gaynes BN, et al.: Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology 2007, 32:2479–2489.

    Article  CAS  PubMed  Google Scholar 

  46. Szegedi A, Jansen WT, van Willigenburg AP, et al.: Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry 2009, 70:344–353.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California, San Diego, 3350 La Jolla Village Drive #116A, San Diego, CA, 92161, USA

    Sanjai Rao

Authors
  1. Sanjai Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjai Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rao, S. Anxious depression: Clinical features and treatment. Curr Psychiatry Rep 11, 429–436 (2009). https://doi.org/10.1007/s11920-009-0065-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-009-0065-2

Keywords

Search

Navigation